Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline of presentation
- Biobanking basics
- What is a biobank?
- US NCI Epidemiologic Biorepository
- Important considerations for setting up a biobank
- Factors affecting facility design
- Other facility considerations
- Types of records maintained
- Technical issues in biobanking
- Quality management in biobanking
- Coordination of biospecimen practices
- Acquiring specimens and data
- Best practices
- NCI best practices for biospecimen resources
- NCI Best Practices overview
- Web version of NCI best practices
- CAP's biorepository accreditation program
- CAP’s biorepository checklist
- International efforts to develop and harmonize best practices
- Biospecimen best practices
- International best practices
- Controlling variability:
- The background of clinical samples
- Sample handling methods
- Effect of pre-analytical variables
- Pre-analytical variables impact clinical and research outcomes
- HER2 assay issues: quantifiable benefits of standardization
- Biospecimen methods studies
- Biobanking networks: success factors & key benchmarks
- Biobank networks and international collaborations
- Examples of biobank networks and governance approaches
- Qualities of well-designed biobanking networks
- Biorepositories for molecular epidemiologic studies
- SOP – Standard operating procedure
- Biobanking economics and sustainability:
- Economic considerations for setting up a biorepository
- Biobanking cost modeling
- Summary of BBRB initiatives
- Biobankonomics
- Business planning
- Fundamental factors that drive value
- Progress in addressing biobank economic issues
- Current hot topics in international biobanking
- Critical issues research
- Current critical issues in international biobanking
- Ethical, legal, and social Issues (Bioethics)
- Additional resources
- International biobanking organizations
- The US NCI BBRB
- ISBR mission statement
- ISBER 2016 convention
- The official journal of ISBER
- Top journals for biospecimen science
- References
- Thank you for your attention!
Topics Covered
- Biobanking basics: best practices, infrastructure, quality management
- International efforts to develop and harmonize best practices
- Controlling variability: critical to international exchange of specimens and data
- Biobanking networks and factors for success
- Economics and sustainability
- Current hot topics in international biobanking
- Additional resources: biobanking organizations, web sites, publications
Talk Citation
Vaught, J. (2016, February 29). International biobanking: overview of key practices and policies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 25, 2024, from https://doi.org/10.69645/SZWD7637.Export Citation (RIS)
Publication History
Financial Disclosures
- Jim Vaught is compensated for his position as Editor-in-Chief of the journal Biopreservation & Biobanking (about $7,200 per year).
International biobanking: overview of key practices and policies
Other Talks in the Series: Tissue in Research
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Jim Vaught.
I'm President
of the International Society
for Biological and Environmental
Repositories or ISBER,
which I'll be referring to
a lot during the presentation.
And I'm also Editor-in-Chief
of the Journal Biopreservation
and Biobanking.
In this presentation,
we'll be talking about
international biobanking
and overview of key practices
and policies.
0:22
The outline of my presentation.
I will be going through
biobanking basics,
best practices, infrastructure,
quality management, for example,
international efforts
to develop and harmonize
best practices for biobanks,
controlling variability,
which is critical
to international exchange
of specimens and data,
biobanking networks
and factors for their success,
the economics and sustainability
of biobanks,
which is a very hot topic
at present
and other current hot topics
in international biobanking.
And then, I'll present
some additional resources,
such as biobanking
organizations,
web sites
and relevant publications.
1:06
So what is a biobank?
A biobank is an entity
that receives, stores,
processes
and, or disseminates specimens.
And some examples are blood,
tissue samples, urine samples,
saliva and others that's needed
for the investigation.
And the biobanking term
encompasses
the physical location as well as
the full range
of operational activities.
And it can be one freezer
or a free-standing entity
within a laboratory
or clinical operation
or part of a larger institution.
And a biobank
has a professional staff
and a commitment to maintain
and preserve specimens
and records for future reference
and historical continuity.
Biobanks may also be called
biorepositories,
biospecimen resources
or biological resource centers.